As GM-CSF, a major survival factor for MDSC was identified in the 5T33MMvt-CM by cytokine array (Supplementary Figure 2), we investigated the effect of a GM-CSF blocking antibody and found that the pro-survival effect of the MM-CM could be abrogated (Figure 4B–4C). The gene discussed is CSF2; the disease is Miyoshi myopathy.